Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014 General Funding Conditions for Funding Contracts as amended (version 1 from 2013) Guide for Individual Projects of Experimental Development, version 2.0 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.
Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: the The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 12/21/2017 General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) Guide for Individual Projects of Experimental Development, version 2.0 3.3 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.1
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.
Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: the The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 07/07/2016. General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) Guide for Individual Projects of Experimental Development, version 2.0 3.1 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.
Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: · the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014 · General Funding Conditions for Funding Contracts as amended (version 1 from 2013) · Guide for Individual Projects of Experimental Development, version 2.0 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.
Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: the · The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 07/07/2016. · General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) · Guide for Individual Projects of Experimental Development, version 2.0 3.1 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.
Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: the · The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 12/21/2017 · General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) · Guide for Individual Projects of Experimental Development, version 2.0 3.3 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.1
Appears in 1 contract
Samples: HOOKIPA Pharma Inc.